Marker Therapeutics Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors
"We are excited to announce the appointment of
To receive future press releases via email, please visit: https://www.markertherapeutics.com/email-alerts.
View original content to download multimedia:https://www.prnewswire.com/news-releases/marker-therapeutics-appoints-biotech-executive-katharine-knobil-md-to-board-of-directors-301440745.html
Investors, Solebury Trout, Xuan Yang, (646) 378-2975, email@example.com; Media, Solebury Trout, Amy Bonanno, (914) 450-0349, firstname.lastname@example.org